Company
Headquarters: Seoul, South Korea
₩951.21 Billion
KRW as of July 1, 2024
US$687.5 Million
| Company | Market Cap (USD) |
|---|---|
| Intuitive | $154.23 B |
| EssilorLuxottica SA | $98.99 B |
| Becton, Dickinson and Company | $65.82 B |
| Alcon Inc. | $43.72 B |
| HOYA Corp | $42.76 B |
| Company | Market Cap (USD) |
|---|---|
| Lilly | $808.65 B |
| Novo Nordisk | $622.07 B |
| UnitedHealth Group | $450.89 B |
| Johnson & Johnson | $350.63 B |
| Merck | $318.75 B |
Dentium Co.,Ltd. manufactures and sells dental implant products worldwide. Its dental implant systems include superline, implantium, simpleline II, slimline, overdenture system, NR line, and implantium II. The company also provides surgical instruments, such as surgical, drill stopper, sinus, osteotome, trephine bur, prosthetic, planning, restorative, and help kits, as well as harvest drills, sinus elevators, GBR systems, surgical guides, temporary shells, white seals, TN brushes, and guide systems; regeneration products, including bone grafts, membranes, and tissue regeneration products; and digital dentistry products. In addition, it offers lab products; and iCT motors and injections. The company was formerly known as Biostech Co., Ltd. and changed its name to Dentium Co.,Ltd. in August 2002. The company was founded in 2000 and is headquartered in Seoul, South Korea.
Top 1-year algo backtest: +265.99%
$10,000 in October 2023 would now be $36,599 by following this algorithm daily at market close.
Use AI to boost your investing & swing trading, now!
Try Disfold DeepFinance FREE
Dentium CO. Ltd has the following listings and related stock indices.
Stock: KRX: 145720 wb_incandescent